• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comparison of chemical inhibitors of antiapoptotic Bcl-2-family proteins.

作者信息

Zhai D, Jin C, Satterthwait A C, Reed J C

出版信息

Cell Death Differ. 2006 Aug;13(8):1419-21. doi: 10.1038/sj.cdd.4401937. Epub 2006 Apr 28.

DOI:10.1038/sj.cdd.4401937
PMID:16645636
Abstract
摘要

相似文献

1
Comparison of chemical inhibitors of antiapoptotic Bcl-2-family proteins.抗凋亡Bcl-2家族蛋白化学抑制剂的比较
Cell Death Differ. 2006 Aug;13(8):1419-21. doi: 10.1038/sj.cdd.4401937. Epub 2006 Apr 28.
2
ApoG2 inhibits antiapoptotic Bcl-2 family proteins and induces mitochondria-dependent apoptosis in human lymphoma U937 cells.ApoG2抑制抗凋亡Bcl-2家族蛋白，并在人淋巴瘤U937细胞中诱导线粒体依赖性凋亡。
Anticancer Drugs. 2008 Nov;19(10):967-74. doi: 10.1097/CAD.0b013e32831087e8.
3
Structure-activity relationship studies of ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (HA 14-1), an antagonist for antiapoptotic Bcl-2 proteins to overcome drug resistance in cancer.2-氨基-6-溴-4-(1-氰基-2-乙氧基-2-氧代乙基)-4H-色烯-3-羧酸乙酯（HA 14-1）的构效关系研究，一种抗凋亡Bcl-2蛋白拮抗剂以克服癌症中的耐药性
J Med Chem. 2006 Dec 28;49(26):7731-9. doi: 10.1021/jm060968r.
4
Combined proteasome and Bcl-2 inhibition stimulates apoptosis and inhibits growth in EBV-transformed lymphocytes: a potential therapeutic approach to EBV-associated lymphoproliferative diseases.蛋白酶体与Bcl-2联合抑制可刺激EBV转化淋巴细胞的凋亡并抑制其生长：一种针对EBV相关淋巴增殖性疾病的潜在治疗方法。
Eur J Haematol. 2008 May;80(5):407-18. doi: 10.1111/j.1600-0609.2008.01044.x. Epub 2008 Jan 23.
5
Apoptosis-based dual molecular targeting by INNO-406, a second-generation Bcr-Abl inhibitor, and ABT-737, an inhibitor of antiapoptotic Bcl-2 proteins, against Bcr-Abl-positive leukemia.第二代Bcr-Abl抑制剂INNO-406与抗凋亡Bcl-2蛋白抑制剂ABT-737基于细胞凋亡的双分子靶向作用，用于治疗Bcr-Abl阳性白血病。
Cell Death Differ. 2007 Sep;14(9):1667-77. doi: 10.1038/sj.cdd.4402168. Epub 2007 May 18.
6
[Progress in small-molecule inhibitors of Bcl-2 family proteins].[Bcl-2家族蛋白小分子抑制剂的研究进展]
Yao Xue Xue Bao. 2008 Jul;43(7):669-77.
7
Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins.用ABT-737（一种新型Bcl-2家族蛋白小分子抑制剂）对胶质母细胞瘤进行基于细胞凋亡的治疗。
Oncogene. 2008 Nov 6;27(52):6646-56. doi: 10.1038/onc.2008.259. Epub 2008 Jul 28.
8
Acylpyrogallols as inhibitors of antiapoptotic Bcl-2 proteins.酰基连苯三酚作为抗凋亡Bcl-2蛋白的抑制剂
J Med Chem. 2008 Feb 28;51(4):717-20. doi: 10.1021/jm701358v. Epub 2008 Feb 1.
9
In memoriam of a prominent composer of the Bcl-2 family symphony.
Cell Death Differ. 2006 Aug;13(8):1248-9. doi: 10.1038/sj.cdd.4401998.
10
Is MAC the knife that cuts cytochrome c from mitochondria during apoptosis?MAC是细胞凋亡过程中从线粒体切割细胞色素c的“刀”吗？
Cell Death Differ. 2006 Aug;13(8):1387-95. doi: 10.1038/sj.cdd.4401949. Epub 2006 May 5.

引用本文的文献

1
Targeting Bcl-2 with Indole Scaffolds: Emerging Drug Design Strategies for Cancer Treatment.靶向Bcl-2的吲哚类化合物：癌症治疗中新兴的药物设计策略
Mini Rev Med Chem. 2025;25(4):293-318. doi: 10.2174/0113895575306176240925094457.
2
Block Copolymer Encapsulation of Disarib, an Inhibitor of BCL2 for Improved Chemotherapeutic Potential.Disarib（一种BCL2抑制剂）的嵌段共聚物封装以提高化疗潜力。
ACS Omega. 2023 Oct 19;8(43):40729-40740. doi: 10.1021/acsomega.3c05802. eCollection 2023 Oct 31.
3
Bcl-B: an "unknown" protein of the Bcl-2 family.
Bcl-B：Bcl-2 家族中的一种“未知”蛋白。
Biol Direct. 2023 Oct 30;18(1):69. doi: 10.1186/s13062-023-00431-4.
4
Cancer Cell Membrane Wrapped Nanoparticles for the Delivery of a Bcl-2 Inhibitor to Triple-Negative Breast Cancer.癌细胞膜包裹的纳米颗粒用于递送 Bcl-2 抑制剂至三阴性乳腺癌。
Mol Pharm. 2023 Aug 7;20(8):3895-3913. doi: 10.1021/acs.molpharmaceut.3c00009. Epub 2023 Jul 17.
5
AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma.AT-101增强来那度胺对多发性骨髓瘤患者的抗肿瘤活性。
Cancers (Basel). 2023 Jan 12;15(2):477. doi: 10.3390/cancers15020477.
6
Anticancer Profile of Rhodanines: Structure-Activity Relationship (SAR) and Molecular Targets-A Review.金雀花堿类化合物的抗癌特性：构效关系（SAR）和分子靶点——综述。
Molecules. 2022 Jun 10;27(12):3750. doi: 10.3390/molecules27123750.
7
Strategies to Reduce the On-Target Platelet Toxicity of Bcl-x Inhibitors: PROTACs, SNIPERs and Prodrug-Based Approaches.降低 Bcl-x 抑制剂靶向血小板毒性的策略：PROTACs、SNIPERs 和基于前药的方法。
Chembiochem. 2022 Jun 20;23(12):e202100689. doi: 10.1002/cbic.202100689. Epub 2022 Mar 19.
8
B Cell Lymphoma 2: A Potential Therapeutic Target for Cancer Therapy.B 细胞淋巴瘤 2：癌症治疗的潜在治疗靶点。
Int J Mol Sci. 2021 Sep 28;22(19):10442. doi: 10.3390/ijms221910442.
9
Design, Synthesis, Anticancer Activity, and Solid Lipid Nanoparticle Formulation of Indole- and Benzimidazole-Based Compounds as Pro-Apoptotic Agents Targeting Bcl-2 Protein.基于吲哚和苯并咪唑的化合物作为靶向Bcl-2蛋白的促凋亡剂的设计、合成、抗癌活性及固体脂质纳米粒制剂
Pharmaceuticals (Basel). 2021 Feb 1;14(2):113. doi: 10.3390/ph14020113.
10
Bcl-2 Enhances Chimeric Antigen Receptor T Cell Persistence by Reducing Activation-Induced Apoptosis.Bcl-2通过减少激活诱导的细胞凋亡增强嵌合抗原受体T细胞的持久性。
Cancers (Basel). 2021 Jan 8;13(2):197. doi: 10.3390/cancers13020197.